Fund Holdings — Opaleye Management Inc.

Total Portfolio Value:
$449.15M
Total Bought:
$133.07M
Total Sold:
$175.76M
Net Transaction:
-$42.69M
Notable People:
James Aaron Silverman
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Harrow, Inc.(HROW)3,990,0003,955,000-35,000$133.86M$105.20M23.42%-$28.66M
Eton Pharmaceuticals, Inc.(ETON)2,852,0702,852,0700$37.99M$37.02M8.24%-$969.7K
SANUWAVE Health, Inc.(SNWV)0972,002+972,002$0$34.38M7.65%+$34.38M
Liquidia Corporation(LQDA)1,698,1422,260,000+561,858$19.97M$33.34M7.42%+$13.36M
Rhythm Pharmaceuticals, Inc.(RYTM)500,000490,000-10,000$27.99M$25.96M5.78%-$2.03M
Codexis, Inc.(CDXS)8,840,0009,500,000+660,000$42.17M$25.55M5.69%-$16.61M
Immunome, Inc.(IMNM)2,040,0003,550,000+1,510,000$21.66M$23.89M5.32%+$2.23M
TG Therapeutics, Inc.(TGTX)2,260,000535,000-1,725,000$68.03M$21.10M4.70%-$46.93M
Arvinas, Inc.(ARVN)1,625,0001,975,000+350,000$33.64M$13.86M3.09%-$19.78M
Ocular Therapeutix, Inc.(OCUL)4,342,5001,595,000-2,747,500$37.08M$11.69M2.60%-$25.39M
Edgewise Therapeutics, Inc.(EWTX)480,000395,000-85,000$12.82M$8.69M1.93%-$4.13M
Protara Therapeutics, Inc.(TARA)1,825,0001,730,000-95,000$9.64M$7.37M1.64%-$2.27M
Ginkgo Bioworks Holdings, Inc.CL A(DNA)1,200,0001,195,000-5,000$11.78M$6.81M1.52%-$4.97M
Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS)000$6.09M$6.32M1.41%+$228.9K
Anika Therapeutics Inc0395,000+395,000$0$5.94M1.32%+$5.94M
Protagonist Therapeutics Inc105,000105,0000$4.05M$5.08M1.13%+$1.02M
Xoma Corp Del250,000253,043+3,043$6.57M$5.04M1.12%-$1.53M
Trevi Therapeutics, Inc.(TRVI)2,317,500795,000-1,522,500$9.55M$5.00M1.11%-$4.55M
Palvella Therapeutics, Inc.(PVLA)0172,357+172,357$0$4.82M1.07%+$4.82M
Gossamer Bio, Inc.(GOSS)4,490,0004,287,415-202,585$4.06M$4.72M1.05%+$654.5K
Anaptys Bio Inc0250,933+250,933$0$4.66M1.04%+$4.66M
Karyopharm Therapeutics IncNOTE 3 000 10 1000$4.67M$4.56M1.01%-$112.7K
Disc Medicine, Inc.(IRON)085,000+85,000$0$4.22M0.94%+$4.22M
Larimar Therapeutics, Inc.(LRMR)01,914,077+1,914,077$0$4.12M0.92%+$4.12M
CG Oncology, Inc.(CGON)0163,988+163,988$0$4.02M0.89%+$4.02M
Acelyrin Inc2,235,0001,615,000-620,000$7.17M$3.99M0.89%-$3.19M
AVITA Medical, Inc.(RCEL)0440,000+440,000$0$3.58M0.80%+$3.58M
Essa Pharma Inc2,209,9982,209,9980$3.96M$3.49M0.78%-$464.1K
Zentalis Pharmaceuticals, Inc.(ZNTL)1,767,5001,985,000+217,500$5.36M$3.16M0.70%-$2.20M
Cargo Therapeutics Inc750,000666,503-83,497$10.81M$2.71M0.60%-$8.10M
Zymeworks Inc.(ZYME)0175,000+175,000$0$2.08M0.46%+$2.08M
Biodesix, Inc.(BDSX)3,465,0003,225,000-240,000$5.30M$2.02M0.45%-$3.29M
Stoke Therapeutics, Inc.(STOK)25,000300,000+275,000$275.8K$2.00M0.44%+$1.72M
MBX Biosciences, Inc.(MBX)0250,000+250,000$0$1.84M0.41%+$1.84M
Optinose Inc0193,039+193,039$0$1.77M0.39%+$1.77M
Opus Genetics, Inc.(IRD)01,175,000+1,175,000$0$1.55M0.34%+$1.55M
iBio, Inc.(IBIO)375,000375,0000$918.8K$1.51M0.34%+$588.8K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)062,501+62,501$0$1.39M0.31%+$1.39M
Nurix Therapeutics, Inc.(NRIX)378,500115,000-263,500$7.13M$1.37M0.30%-$5.76M
Rezolute, Inc.(RZLT)465,000465,0000$2.28M$1.35M0.30%-$930.0K
Sangamo Therapeutics, Inc.(SGMOQ)01,055,000+1,055,000$0$691.9K0.15%+$691.9K
PepGen Inc.(PEPG)110,000420,000+310,000$416.9K$590.1K0.13%+$173.2K
Journey Medical Corporation(DERM)069,323+69,323$0$409.0K0.09%+$409.0K
Ventyx Biosciences Inc280,000190,000-90,000$613.2K$218.5K0.05%-$394.7K
Adagio Medical Holdings, Inc.(ADGM)110,571110,5710$116.1K$92.1K0.02%-$24.0K
AbCellera Biologics Inc.(ABCL)965,0000-965,000$2.83M$0—-$2.83M
Immatics N.V.(IMTX)165,0000-165,000$1.17M$0—-$1.17M
Jasper Therapeutics, Inc.(JSPR)400,0000-400,000$8.55M$0—-$8.55M
Lexeo Therapeutics, Inc.(LXEO)130,0000-130,000$855.4K$0—-$855.4K
Newamsterdam Pharma Company
ORDINARY SHARES
325,0000-325,000$8.35M$0—-$8.35M
Nuvalent Inc58,5000-58,500$4.58M$0—-$4.58M
REGENXBIO Inc.(RGNX)80,0000-80,000$618.4K$0—-$618.4K
UroGen Pharma Ltd.(URGN)220,0000-220,000$2.34M$0—-$2.34M
Vaxcyte, Inc.(PCVX)75,0000-75,000$6.14M$0—-$6.14M
Page 1 of 1
Opaleye Management Inc. — 13F Holdings — Q1 2025 | TickerTrail